FDA inspection

Syngene USA Inc.: FDA inspection ending Apr 20, 2021

FDA inspection 1141685 · Official Action Indicated (OAI) · Baltimore, MD

Key facts

Inspection ID 1141685
Firm Syngene USA Inc.
FEI number 3015448605
Address 5901 E Lombard St
City Baltimore
State MD
ZIP 21224
Country United States
Fiscal year 2021
Inspection end date Apr 20, 2021
Classification Official Action Indicated (OAI)
Project area Vaccines and Allergenic Products
Product type Biologics

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections